begin developing snri special focus norepinephrine molecules known duloxetine later branded cymbalta eli lilly applies patent duloxetine company receives patent eli lilly runs large multinational clinical trials conducted phases ii iii food drug administration requires approving new drug eli lilly wraps phase tests drug safety phase ii looks efficacy 2002 study example 267 depressed adults took duloxetine placebo weeks taking duloxetine fewer symptoms depression physical pain eli lilly completes phase iii trials 21 sites europe russia step scientists compare duloxetine drugs market attempt identify correct dosage 2004 study 367 depressed patients instance found daily duloxetine doses 40 80 milligrams offered